- Why Cryoport
- Who We Serve
- About Us
- News & Events
- Investor Relations
- Contact Us
Secure, GMP-compliant, controlled-temperature storage at the following temperatures:
All storage in validated equipment with full temperature monitoring, redundant infrastructure, backup storage units, and on-call technicians.
Secondary packaging and compliant labeling of drug product and other materials:
Our EU locations will provide Qualified Person (QP) oversight of import and release as required by EU Clinical Trials Directive 2001/20/EC and Annex 13 of EU GMP Guide:
We handle all aspects of the return process, including:
Production and distribution of all types of kits (including apheresis, blood/tissue collection, manufacturing, drug administration, etc).
BioServices will be introduced at select current and future Cryoport Logistics Centers.
Morris Plains, New Jersey
Additional locations to be announced in the near future.
We expect the Houston and Morris Plains facilities to be operational by the end of Q4 2021.